หน้าหลัก

F mass drug administration around the association amongst ocular Chlamydia MK-2206 Technical Information trachomatis infection and follicular trachoma in preschool-aged children. PLoS Negl Trop Dis. 2014;8:e2761. 9. Munoz B, Stare D, Mkocha H, et al. Can clinical indicators of trachoma be utilized right after a number of rounds of mass antibiotic therapy to indicate infection? Invest Ophthalmol Vis Sci. 2011;52:8806?810. ten. Michel CE, Roper KG, Divena MA, Lee HH, Taylor HR. Correlation of clinical trachoma and infection in Aboriginal communities. PLoS Negl Trop Dis. 2011;five:e986. 11. Hu VH, Harding-Esch EM, Burton MJ, et al. Epidemiology and control of trachoma: systematic assessment. Trop Med Int Well being. 2010;15:673?91. 12. Wright HR, Taylor HR. Clinical examination and laboratory tests for estimation of trachoma prevalence inside a remote setting: what are they really telling us? Lancet Infect Dis. 2005;five:313?20. 13. West ES, Munoz B, Mkocha H, et al. Mass treatment as well as the effect on the load of Chlamydia trachomatis infection within a trachoma-hyperendemic neighborhood. Invest Ophthalmol Vis Sci. 2005;46:83?7. 14. Miller K, Schmidt G, Melese M, et al. How reputable will be the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiol. 2004;11:255?62. 15. Burton MJ, Holland MJ, Faal N, et al. Which members of a community require antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci. 2003;44:4215?222. 16. Taylor HR, Rapoza P, West SK, et al. The epidemiology of infection in trachoma. Invest Ophthalmol Vis Sci. 1989;30: 1823?833. 17. Mabey DC, Hu V, Bailey RL, Burton MJ, Holland MJ. Towards a safe and helpful chlamydial vaccine: lessons in the eye. Vaccine. 2014;32:1572?578. 18. Miller K, Schmidt G, Melese M, et al. How trusted would be the clinical exam in detecting ocular chlamydial infection? Ophthalmic Epidemiol. 2004;11:255?62. 19. Keenan JD, Lakew T, Alemayehu W, et al. Clinical activity and polymerase chain reaction evidence of chlamydial infection immediately after repeated mass antibiotic treatments for trachoma. Am J Trop Med Hyg. 2010;82:482?87. 20. West ES, Munoz B, Mkocha H, et al. Mass treatment and also the effect around the load of Chlamydia trachomatis infection in a trachoma-hyperendemic neighborhood. Invest Ophthalmol Vis Sci. 2005;46:83?7. 21. Thein J, Zhao P, Liu H, et al. Does clinical diagnosis indicate ocular chlamydial infection in locations with a low prevalence of trachoma? Ophthalmic Epidemiol. 2002;9:263?69. 22. Taylor HR, Johnson S, Prendergast R, et al. An animal model of trachoma: the importance of repeated reinfection. Invest Ophthalmol Vis Sci. 1982;23:507?15. 23. Burr SE, Hart JD, Edwards T, et al. Association among ocular bacterial carriage and follicular trachoma following mass azithromycin distribution in the Gambia. PLoS Negl Trop Dis. 2013;7:e2347. 24. Burton MJ, Hu VH, Massae P, et al. What is causing active trachoma? The function of nonchlamydial bacterial pathogens inside a low prevalence setting. Invest Ophthalmol Vis Sci. 2011;52: 6012?017.FIGURE 2. Prevalence of trachoma excluding and including situations of TI alone.present as TI circumstances have high prices of infection, nevertheless it does not add programmatically to choices on treatment.